State Street SPDR S&P Health Care Equipment ETF XHE
92.50 USD -0.13 (-0.14%)
At closeNov 3, 2026, 4:00 PM EST
92.50 0.00 0.00%
After hours · Nov 3, 4:00 PM ET
92.50 Day range 93.05
76.00 52-week range 97.65
- YTD
- +4.84%
- 1 year
- +15.05%
- Market cap
- 152.76M
- EPS (ttm)
- 3.31
- P/E ratio
- 27.93
- YTD return
- +4.84%
- 1-year return
- +15.05%
- Volume
- 9.51K
- Avg volume
- 30.24K
- Open
- 92.66
- Previous close
- 92.63
- Day's range
- 92.50 – 93.05
- 52-week range
- 76.00 – 97.65
2Y +2.97 (+3.30%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 90.27
- 200-day average
- 87.01
About State Street SPDR S&P Health Care Equipment ETF
In seeking to track the performance of the S&P Health Care Equipment Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the health care equipment segment of the S&P Total Market Index ("S&P TMI").
News
Haemonetics Stock Hits 52-Week High - Here's Why 
SPDR S&P Health Care Equipment ETF (NYSEARCA:XHE) Stock Price Down 0.5% – Here’s Why 
XHE: Health Care Equipment Likely To Underperform Amid Higher Rates (Downgrade) 
Bank of America Corp DE Boosts Stake in SPDR S&P Health Care Equipment ETF $XHE 
Leadership Shifts Toward Quality Stocks? Sector ETFs to Play 
The Hormuz Reopening Trade Nobody Is Talking About: 20 Gold And Silver Mining Stocks To Watch 
Hologic Goes Private In $18 Billion Blackstone, TPG Acquisition 
NovoCure Tumor Treating Fields Shows Improved Outcomes In Tough Pancreatic Cancer 
Insulet Stock Hits 52-Week Low - Here's Why 
FDA Expands Approval For Staar Surgical's Popular Implantable Lens
Your note
Sign in to keep a note on XHE — it syncs with the Stock Master app.